S B, man aged 30. Lorry driver History: Ten years ago whilst in the army in Korea -he noted increased pigmentation of face and backs of hands. His identical twin brother, who was with him in Korea, noticed the same phenomenon. The hyperpigmentation persisted when he returned to England and was of such a degree that friends and relatives commented on it. Since that time he has observed that any slight trauma to the backs of the hands readily damages the skin, producing a raw area which heals very slowly leaving a brown mark at the site. If the trauma is by a blunt object a blister forms. His twin brother has had similar but more severe lesions.
When sunbathing he tans very readily and his face becomes tight and tingling after a couple of hours' exposure. However, sun exposure causes no other symptoms and he enjoys it. In cold weather he complains that his fingers become swollen and stiff with tingling in the finger tips on rewarming. He has episodes of griping abdominal pain about twice weekly lasting for 20 to 30 minutes; it is uncomfortable but not severe. He drinks alcohol occasionally but never more than two pints of beer, and no spirits. He has taken white sleeping tablets of unknown type in the past without ill effects.
The patient and his twin brother had tonsillectomy at age 12 with no complications. Apart from the twin brother there was no suggestion of porphyria in the histories of 6 other siblings nor in other family members. Clinical findings: Increased pigmentation on face and hands. Small scars around ears. Superficial pigmented scars over dorsa of hands and a few on arms. Callosities in finger webs. Nohepatomegaly. Other systems normal. Investigations: Hb 14-8 g/100 ml (101 %). PCV 50 %. ESR 1 mm in 1 hour. Monochromatic light testing (Dr T A J Dawson): 'An erythematous response developed from 400 to 600 nm (4,000-6,000 Angstrom units). Compatible with diagnosis of porphyria.' Abnormal biochemical findings (normal values in parentheses): Urinary coproporphyrins 317 6 (1-0-283), uroporphyrins 62-4 (0-41) pg/24 hours; feecal protoporphyrins 821 (0-113), coproporphyrins 500 (0-50) ,ig/g dry weight. Normal biochemical findings: Urine porphobilinogen and urine delta-aminolkvulic acid, erythrocyte porphyrins, serum proteins and electrophoresis, serum bilirubin, alkaline phosphatase, SGOT, SGPT, serum iron, blood urea, fasting blood sugar, bromsulphalein retention and cryoglobulins.
Comment
It is noteworthy that the patient's identical twin brother has paralleled the patient in the development and progression of lesions. The twin brother was seen at a hospital in 1963 when erosions were present on the backs of the hands. They were diagnosed as chrome ulcers. Although the twin brother has not, as yet, been investigated biochemically it seems very likely that he too is suffering from porphyria. Since there have been no obvious provoking agents in this case it appears that he is an example of the hereditary form of porphyria cutanea tarda (Waldenstrom 11957) . Abdominal symptoms are known to occur in these patients, as in members of the families described by Wells & Rimington (1953) and by Woods et al. (1961) .
It is important to estimate stool and urinary porphyrins in the relatives of these patients to reveal unsuspected sufferers from the disease. However, since single random estimations of fical and urinary porphyrins may show normal values in affected individuals it seems wise to follow the practice of Goldberg (1966) in advising all close relatives of porphyria patients to avoid alcohol and the administration of such drugs as barbiturates, chloroquine and griseofulvin.
In this case there was a long history of symptoms before the diagnosis was made. One contributory factor was the absence of a clear-cut history of light intolerance, and indeed the patient enjoyed sunbathing. Thus the consequences of increased skin fragility rather than those arising from light exposure may prompt the patient to seek medical advice.
The presence of callosities in the finger webs has not, so far as we are aware, been previously described in porphyria cutanea tarda. The patient admits to rubbing between the fingers, but even so they are unusual.
Dr G C Wells: In both biopsies, one from the back of -the hand and one from a finger, there is a striking degree of hyaline thickening round superficial capillaries, and this amorphous material is PAS positive. Dr E A Ryan (1966, Brit. J. Derm. 78, 43) has shown this change to be consistently present in the exposed -skin of patients with erythropoietic protoporphyria, and it is seen much less in porphyria cutanea tarda.
The same sort of amorphous, PAS-positive material is seen in lipoid proteinosis, but it occurs much more extensively in the dermis and also affects clothed parts. This change is not seen in other light-sensitive dermatoses. In Dr Ryan's series of 11 patients with porphyria cutanea tarda, only one showed marked pericapillary hyaline changes in the exposed skin, and this man had a raised serum protoporphyrin (Wells & Rimington, 1953, Brit. J. Derm. 65, 337) . I would like to ask whether in the case shown today there might be a raised serum (as opposed to erythrocyte) protoporphyrin?
Dr G M Levene: Plasma contained only traces of coproporphyrin, protoporphyrin, uroporphyrin and porphobilinogen.
The question of treatment arises. Apart from protection from excessive light exposure by a widebrimmed hat and gloves one must consider reports by Ippen (1961), Illin (1963) , Epstein & Redeker (1965) and others that repeated venesections have produced prolonged biochemical and clinical remissions in porphyria cutanea tarda. Investigation into iron metabolism is being carried out in the present patient.
So far values for hemoglobin, packed cell volume and serum iron have been found to be within normal limits. However, it is noteworthy that improvement following repeated venesections does not seem to be necessarily correlated with high initial values of hmemoglobin or of serum iron. The oral use of a chelating agent such as sodium calciumedetate, described by Woods et al. (1961) and Donald et al. (1965) as giving good results, is being considered. We should appreciate any experience of members in the use of such treatments.
Dr S S Bleehen: Recently Dr T B Fitzpatrick in
Boston has been treating several patients with porphyria cutanea tarda by repeated venesections. The results of this form of therapy appear to be encouraging. One patient, who also had an associated hamochromatosis, was definitely improved both as regards her symptoms and her porphyrin levels. Dr M Garretts: I have had one case of porphyria cutanea tarda in which treatment with cysteine and nicotinic acid has been most useful. This regime was suggested by the patient's brother, a general physician in Belgium. He had had experience of cases of this disease precipitated by wine drinking in whom hepatic damage was an important factor. For this reason he gave his cases cysteine and nicotinic acid with considerable improvement in the skin diseases.
My patient had no history of alcoholism and his liver function tests were normal. Despite this he was given cysteine 250 mg three times daily and nicotinic acid 50 mg three times daily. Over the course of three months' treatment he was able to tolerate sun exposure with only minimal skin discomfort. Another patient is being similarly treated but the proof of the value in this second case will not be forthcoming until summer.
Dr R Marks: I showed a case of porphyria cutanea tarda for Dr S C Gold at the St John's Hospital Dermatological Society in 1966. We treated her with cholestyramine without much benefit. If this form of treatment is contemplated it is as well to remember that it is extremely unpleasant to take as a powder and should be put up in capsule form.
Dr R P Warin: In assessing the effect of treatment in porphyria cutanea tarda the natural fluctuations which occur in the disorder must be remembered and patients who at one time had severe exacerbations from exposure to sunlight may at a later date show little or no reaction. One of my patients who had a severe eruption three years ago is now clear and can stand the sunlight exposure from average day-to-day activities.
Dr G A Beck: This patient is worse in the winter; the few lesions he has in the summer heal more rapidly.
Dr Louis Forman: There are differences in the reactions of the skin to light in the different types of porphyria. Could Dr Wells tell us if the PAS-positive hyaline which he has demonstrated in the cutis would vary with the degree of clinical reaction of the skin when exposed to light?
Dr Wells: The hyalinization around the capillaries is seen only in the light-exposed areas. Dr Ryan was careful to do control biopsies from covered areas in her series of patients with erythropoietic protoporphyria. F N, man aged 26. West Indian History: Came to England seven years ago and has lived here continuously since then. Three months ago he developed a granulomatous lesion on the left foot which has been increasing in size. On examination the lesion was an inch (2-5 cm) in diameter with a slightly violaceous border and granulomatous centre (Fig 1) . Biopsy: 'A grossly thickened epidermis underlying a heavy infiltrate of plasma cells, lymphocytes, with polymorphs grouped around necrotic material; also groups of pigmented spores. This is likely to be a chromoblastomycosis'. Mycological examination revealed the presence of Phialophora pedrosoi and was confirmed by culture. 
Fig 1 Granuloma on dorsum offoot
Treatment: A variety of treatments have been suggested, the most recent being thiabendazole, amphotericin B and griseofulvin and tetracycline.
Iodides have also been used but none of these has given more than a 40 % cure rate, according to the literature. It is proposed to excise this lesion and then perhaps carry out local treatment later if necessary.
Dr R D Sweet: I am sure the quickest and safest way to deal with this lesion will be to excise it widely.
Group Captain H E Bellringer: Recently in the Far
East I have seen 3 cases which recurred after excision.
These, and a further case with a lesion which was considered too awkward and extensive to excise were initially treated with griseofulvin, with obvious regression after one month. Then iodide and tetracycline were given with further clearance. One postoperative recurrence had completely disappeared one month after starting the second part of the treatment. The considerable variability in the species of organisms found in the various areas where the disease is encountered may account for some of the differences in response to treatment.
Dr M M Walshe: When I was in Jamaica I tried the effect of intralesional amphotericin B. Although the usual extent of lesions seen in that country is too great to obtain complete clearing in this way, considerable clearing at the site of injection occurs. I think it might be worth trying for this fairly small lesion.
Professor J T Ingram: In Australia I saw many patients with this disease. Because of its resemblance to tuberculosis verrucosa cutis and being purely a skin disease I suggested the local application of pyrogallic acid paste. I understand it was successful. Postscript (3.5.68): The lesion has now been excised and grafted and has healed without recurrence. -S A
